ARKRAY, Inc. engages in the manufacture and sale of medical and surgical equipment. It develops products that focus on diabetes testing and urinalysis. It also provides the medical testing systems and functional food materials. The company was founded by Tadashi Doi on June 10, 1960 and is headquartered in Kyoto, Japan.

Yamasa Corp. manufactures and supplies soy sauce and seasonings. It processes and supplies soy sauce, seasonings, sauces, dips, and flavorings. The firm also develops pharmaceuticals and biochemicals. The company was founded in 1645 and is headquartered in Choshi, Japan.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Givaudan is engaged in the research, development, manufacture, and sale of fragrances and flavor products. It was founded in 1895 and is based in Vernier, Switzerland.

Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.

Manufactures pharmaceuticals

Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA.

Degussa AG is the world's third largest producer of precious metals. The company operates three divisions; precious metals and banking, which is involved in precious metals trading, production of precious metals and the manufacture of precious metal compounds and products in addition to operating its own bank, 'Degussa Bank', which is a universal bank providing traditional banking services. Chemical products is the second division and is involved in manufacturing fine and special chemicals, rubbers, pigments and chemical catalysts. The third and final division, health and nutrition is involved in manufacturing pharmaceuticals, dental chemicals and fodder additives. The company has subsidiaries in Germany, other European countries, USA, Brazil, Singapore, Japan and South Korea.

Amano Enzyme, Inc. manufactures and distributes enzymes for pharmaceuticals, food and diagnostics. It also produces and sells feed additives, drugs, and animal drugs. The company was founded in 1899 by Ennosuke Amano and is headquartered in Nagoya, Japan.

EWOS AS operates as a supplier of feed and nutrition for the international aquaculture industry. The firm offers salmon feed innovation and has helped transform the industry, supporting growth in sustainable salmon farming methods. It is poised to benefit from the increasing demand of global consumers for healthier forms of protein such as salmon. The company was founded in 1931 and is headquartered in Bergen, Norway.

SyneuRx International (Taiwan) Corp. engages in the manufacture and sale of medicines. It offers different kinds of medicines, which are useful for brain disorders like schizophrenia have largely failed to materialize and mental illnesses like depression, obsessive compulsive disorder, attention deficit hyperactivity disorder, autism and dementia. The company was founded by Kuo Chuan Tsai on April 2, 2013 and is headquartered in New Taipei, Taiwan.

Part of Givaudan SA, Givaudan Fragrances Corp. is a company headquartered in Teaneck, NJ, that manufactures and extracts cosmetics.

Shaanxi Hongdao Bioanalytical Science and Technology Research Institute Co., Ltd., established on 2019-12-11, Business scope includes high-tech products,High-tech biological products,Medicine and health products,Chinese herbal medicine,Research and development of bioengineering technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

Roche Diagnostics GmbH, part of Roche Holding AG, is a company headquartered in Mannheim, Germany, involved in laboratory analytical instruments. Andreas Schmitz and Claus Haberda are the current co-CEOs of the firm. On January 01, 1999 Roche Holding AG acquired Roche Diagnostics GmbH.

Shanghai Biotech Co., Ltd. is a modern science and technology enterprise integrating production and research. It is mainly committed to the R&D, production and sales of genetically engineered enzyme preparations, as well as the industrial application, development and promotion of the above enzyme preparations. Biolonase nuclease series products can be widely used in biological products to reduce nucleic acid residues and eliminate the interference of nucleic acid on biological sample separation and analysis. The product quality is consistent with that of Benzonase, but the price is far lower than that of imported products. It provides customers with low-cost solutions to reduce product DNA residues, and is a substitute for Benzoanse. Chondroitinase series can be used for the research and analysis of related polysaccharides, and it is also a tool to improve the production of heparin and heparin like products. It can greatly simplify the production process, improve the product quality and yield. The company adheres to the business philosophy of integrity, quality and service, is responsible for customer integrity, strives for excellence in work, and cooperates with partners; Adhere to the enterprise spirit of efficiency, pragmatism, learning and innovation, and provide customers with quality products and services!